Sun Pharma gets approval for generic Gemzar injection

20864 Investors following Sun Pharma. Share this News with them.

0

Like this story, share it with millions of investors on M3

Sun Pharma gets approval for generic Gemzar injection

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company’s Abbreviated New Drug Application for its generic version of Eli Lilly and Co’s Gemzar®, gemcitabine injection.

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Buy Sun Pharma, tgt Rs 1450: HEM Securities Sun Pharma gets approval to mkt generic Demadex tablets Sun Pharma buys Taro Pharma shares from Brandes ALSO READ See latest News about Sun Pharma See previous management interviews See what other Experts & Brokerages are saying about Sun Pharma Sun Pharma BSE | NSE 25/05/12 Are Mutual Funds betting on Sun Pharma?

Sun Pharmaceutical Industries Ltd. announced that USFDA has granted tentative approval for the Company's Abbreviated New Drug Application (ANDA) for its generic version of Eli Lilly and Co's Gemzar®, gemcitabine injection.

These generic gemcitabine injections are therapeutic equivalents of Eli Lilly and Co's Gemzar® injections available in two strengths: 200 mg and 1 g single use vial. These strengths of gemcitabine injections have annual sales of approximately USD 680 million in the US.

Gemcitabine is an anticancer, used singly or in combination with other anticancer agents. 

Sourced from: Sun Pharmaceutical Industries Ltd